Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 169-173, February 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Becker, F. F.
Right arrow Articles by Klein, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Becker, F. F.
Right arrow Articles by Klein, K. M.

The Effect of L-Asparaginase on Mitotic Activity during N-2-Fluorenylacetamide Hepatocarcinogenesis: Subpopulations of Nodular Cells1

Frederick F. Becker2 and Kenneth M. Klein3

Department of Pathology, New York University School of Medicine, New York, New York 10016

Normal rat liver hepatocytes and the hepatocytes of hepatic nodules induced by N-2-fluorenylacetamide respond to 70% hepatectomy with vigorous mitotic activity. The administration of L-asparaginase at the time of operation delays the mitotic cycle of every normal hepatocyte by 10 to 12 hr. When L-asparaginase was administered to rats which had received N-2-fluorenylacetamide, an 80% inhibition of mitotic activity of the hepatocytes of the nodules occurred. However, aggregates of cells resistant to the effect of the enzymes were noted in a number of nodules. These resistant cells represent a metabolic subpopulation within the hyperplastic nodule.

1 Supported by American Cancer Society Grant E-355C.

2 Career Scientist, Health Research Council of the City of New York.

3 USPHS Fellow in Experimental Pathology.

Received 8/26/70. Accepted 10/ 6/70.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.